Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
9 in 10 employers are concerned about high-cost drugs in the pipeline, with a similar number reporting concern about pharmacy cost trends overall.
A recent hearing at the U.S. House of Representative Health Subcommittee of the Energy and Commerce Committee heard testimony from shareholders and policy experts on costs and price transparency.
Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that likely won’t soon slow, according to interviews with three hospital officials in major U.S. cities, but other factors may also be at play. U.S. health insurers have warned of high demand for medical ...
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010. The drugs have kept his cancer at bay. But their rapidly increasing costs so infuriated Mitchell that he was inspired to create an ...
The National Association of Benefits and Insurance Professionals (NABIP) proudly announces a series of groundbreaking initiatives under the leadership of CEO Jessica Brooks-Woods, the first Black female CEO in the association’s history. With a visionary approach, she is steering NABIP towards harnessing artificial intelligence (AI) to revolutionize health insurance selection and champion health equity, marking a ...
The number of balance billing disputes reaching arbitration is far higher than federal projections suggested, according to new data from the Biden administration. The Centers for Medicare & Medicaid Services (CMS) issued a report this week looking at the number of surprising billing negotiations that reached the independent dispute resolution (IDR) phase of the No ...
Doctors are already using unregulated artificial intelligence tools such as note-taking virtual assistants and predictive software that helps them diagnose and treat diseases. Government has slow-walked regulation of the fast-moving technology because the funding and staffing challenges facing agencies like the Food and Drug Administration in writing and enforcing rules are so vast. It’s unlikely ...
The Biden administration is taking a look at how group purchasing organizations (GPOs) and drug wholesalers are playing a role in generic drug shortages. In a Request for Information jointly issued Wednesday, the Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) said they want to learn more about the organizations’ ...
On January 1, 2024, California took a significant step toward achieving universal health coverage for its residents. By expanding its Medi-Cal program, the state now ensures that every resident, regardless of immigration status, has the opportunity to receive comprehensive medical services and health care coverage.
Fewer than 20% of adults in the United States know the cost of their health care products or services before receiving them, and almost all of them believe health care organizations need to make costs more transparent. What’s more, only about 3 in 10 American adults feel those costs reflect the quality of the products and services they receive.